Tridax Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 29-12-2024
- Paid Up Capital ₹ 0.50 M
as on 29-12-2024
- Company Age 16 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -98.46%
(FY 2020)
- Profit -95.10%
(FY 2020)
- Ebitda 99.61%
(FY 2020)
- Net Worth 6.30%
(FY 2020)
- Total Assets -4.81%
(FY 2020)
About Tridax Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Pulicherla Reddy, Ramakrishna Munnamgi, and Bhavanam Reddy serve as directors at the Company.
- CIN/LLPIN
U24232TG2008PLC061191
- Company No.
061191
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Sep 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Tridax Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pulicherla Reddy  | Director | 02-Feb-2018 | Current |
| Ramakrishna Munnamgi | Director | 25-Mar-2022 | Current |
| Bhavanam Reddy | Director | 02-Feb-2018 | Current |
Financial Performance of Tridax Laboratories.
Tridax Laboratories Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 98.46% decrease. The company also saw a substantial fall in profitability, with a 95.1% decrease in profit. The company's net worth moved up by a moderate rise of 6.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tridax Laboratories?
In 2020, Tridax Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bangalore Industrial Waste Management (Karnataka) Private LimitedActive 12 years 5 monthsBhavanam Reddy is a mutual person
Kvr Baseline Resources Private LimitedActive 13 years 11 monthsRamakrishna Munnamgi is a mutual person
Everblooming Agritech Private LimitedActive 13 years 10 monthsPulicherla Reddy and Bhavanam Reddy are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tridax Laboratories?
Unlock and access historical data on people associated with Tridax Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tridax Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tridax Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
